Influx Healthtech IPO Details

Bookbuilding IPO | ₹59 Cr | Listed at NSE SME | Wed, Jun 18, 2025 - Fri, Jun 20, 2025

Influx Healthtech IPO Logo

Influx Healthtech IPO is a book build issue of ₹58.57 crores. The issue is a combination of fresh issue of 0.50 crore shares aggregating to ₹48.00 crores and offer for sale of 0.11 crore shares aggregating to ₹10.56 crores.

Influx Healthtech IPO bidding started from Jun 18, 2025 and ended on Jun 20, 2025. The allotment for Influx Healthtech IPO was finalized on Jun 23, 2025. The shares got listed on NSE SME on Jun 25, 2025.

Influx Healthtech IPO price band is set at ₹96 per share. The lot size for an application is 1,200. The minimum amount of investment required by an retail is ₹1,15,200 (1200 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (2,400 shares), amounting to ₹2,30,400.

Rarever Financial Advisors Pvt.Ltd. is the book running lead manager and Maashitla Securities Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is R.K.Stock Holding Pvt.Ltd..

Refer to Influx Healthtech IPO RHP for detailed Information.

IPO Open

Wed, Jun 18, 2025

IPO Close

Fri, Jun 20, 2025

Issue Price

₹96 per share

Market Cap (Pre-IPO)

₹222.24 Cr

IPO Details

IPO Date18 to 20 Jun, 2025
Listed onWed, Jun 25, 2025
Face Value10 per share
Price Band₹91 to ₹96
Issue Price₹96 per share
Lot Size1,200 Shares
Sale TypeFresh capital cum OFS
Issue TypeBookbuilding IPO
Listing AtNSE SME

Total Issue Size61,00,800 shares
(agg. up to ₹59 Cr)
Reserved for Market Maker
3,06,000 shares
(agg. up to ₹3 Cr)
R.K.Stock Holding Pvt.Ltd.
Fresh Issue
(Ex Market Maker)
46,94,400 shares
(agg. up to ₹45 Cr)
Offer for Sale11,00,400 shares of ₹10
(agg. up to ₹11 Cr)
Net Offered to Public57,94,800 shares
(agg. up to ₹56 Cr)
Share Holding Pre Issue1,81,50,000 shares
Share Holding Post Issue2,31,50,400 shares
NSE Symbol INFLUX
ISININE0MYZ01012

IPO Timetable

Issue Reservation

Influx Healthtech IPO comprises a total issue size of 61,00,800 shares. The net offer to the public is 57,94,800 shares, after excluding 3,06,000 shares allotted on a firm basis. Of the Net offer 28,95,600 (49.97%) are allocated to QIB, 8,70,000 (15.01%) allocated to NII 20,29,200 (35.02%) allocated to RII.

Investor Category Shares Offered % of Net Issue% of Total Issue
QIB Shares Offered 28,95,60049.97%47.46%
  − Anchor Investor Shares Offered 17,36,40028.46%
  − QIB (Ex. Anchor) Shares Offered 11,59,20019.00%
NII (HNI) Shares Offered 8,70,00015.01%14.26%
Retail Shares Offered 20,29,20035.02%33.26%
Firm Reservations
Market Maker Shares Offered 3,06,0005.02%
Total Shares Offered 61,00,800100.00%100.00%

IPO Lot Size

Investors can bid for a minimum of 1,200 shares and in multiples thereof. 

Application Lots Shares Amount
Retail (Min) 1 1,200 ₹1,15,200
Retail (Max) 1 1,200 ₹1,15,200
HNI (Min) 2 2,400 ₹2,30,400
IPO Subscription Details

IPO Anchor Investors

Influx Healthtech IPO raises ₹16.67 crore from anchor investors. Influx Healthtech IPO Anchor bid date is June 17, 2025.
📝 Anchor Investors Letter (PDF)

Bid DateTue, Jun 17, 2025
Shares Offered17,36,400
Anchor Portion (₹ Cr.)16.67
Anchor lock-in period end date for 50% shares (30 Days)Wed, Jul 23, 2025
Anchor lock-in period end date for remaining shares (90 Days)Sun, Sep 21, 2025

About Influx Healthtech Ltd.

Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specialising in contract manufacturing. The company is a reliable CDMO, providing specialized services to clients in multiple industries.

The company has three manufacturing facilities in Thane, Maharashtra, each covering an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.

Product Portfolio:

  • Tablets, Capsules, and Powders
  • Liquid Orals and Softgels
  • Lozenges, Jellies, and Gummies
  • Oral Dispersible Films (ODFs)
  • Effervescent Tablets and Liquid-Fill Capsules
  • Candies and Gym/Sports Supplements
  • Skin Care and Body Care Products
  • Hair Care and Beard Care Solutions
  • Face Masks and Soaps.
  • Ayurvedic / Herbal formulations
  • Veterinary Feed Supplements
  • Homecare solutions

The Company aids Nutraceutical and Cosmetic firms with product development and manufacturing. It offers end-to-end services, including development, production, and regulatory support, enabling clients to focus on formulation and commercialization.

As of June 11, 2025, the company has 163 permanent employees on a payroll basis.

Competitive Strength

  • Diversified Product Portfolio
  • Diverse Clientele
  • Stringent Quality Assurance/Quality Control
  • Experienced and Qualified Promoters and Management team.

Company Financials (Restated)

Influx Healthtech Ltd.'s revenue increased by 5% and profit after tax (PAT) rose by 19% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets70.3041.1028.30
Total Income104.99100.1076.07
Profit After Tax13.3711.227.20
NET Worth36.1522.8711.65
Reserves and Surplus18.0022.8511.63
Total Borrowing0.220.320.80
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects Est Amt (₹ Cr.)
1 Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division 22.60
2 Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division 11.59
3 Purchase of Machineries for Homecare and Cosmetic Division 2.76
4 General corporate purposes 5.44

Key Performance Indicator (KPI)

Pre IPOPost IPO
EPS (₹)7.365.77
P/E (x)13.0416.63
Promoter Holding99.85%73.53%
Market Cap222.24 Cr.
The promoters of the company are Mr. Munir Abdul Ganee Chandniwala, Mrs. Shirin Munir Ahmed Chandniwala and Mr. Abdul Ganee Abdul Rasul Chandniwala.
  • The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2025 available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of March 31, 2025 available in RHP.

IPO Review

[Dilip Davda]
IHL operates as CDMO for healthcare products with its three units. It marked steady progress in its top lines for the reported periods. The sudden boost in its bottom lines for FY24 and FY25 raise eyebrows and concern over its sustainability going forward as it is operating in a highly competitive and fragmented segment. Based on its recent financial data, the issue appears fully priced. Well-informed/cash surplus investors may park moderate funds for medium term.
Read detail review...

Influx Healthtech IPO Recommendations

Review BySubscribeMay ApplyNeutralAvoid
Brokers0100
Members0100

Influx Healthtech IPO Subscription Status (Bidding Detail)

The Influx Healthtech IPO is subscribed 201.35 times on June 20, 2025 6:20:00 PM (Day 3). The public issue subscribed 117.68 times in the retail category, 137.87 times in the QIB category, and 481.10 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)Shares OfferedShares bid forTotal Application
QIB137.8711,59,20015,98,18,40099
NII*481.108,70,00041,85,55,20021,199
Retail117.6820,29,20023,87,97,6001,98,998
Total201.3540,58,40081,71,71,2002,20,296

Total Application : 2,20,296

*Market Maker portion is not included to NII/HNI.

IPO Expenses

# Issue Expenses Est Amt (₹ Cr.)
1 Book Running Lead Manager Issue Management 0.65
2 Underwriting Commission 1.25
3 Advertising and marketing expenses 3.42
4 Printing and distribution of issue stationery 0.00
5 Other Expenses (including Audit Fees, Legal Advisors and Processing Fees) 0.26
6 Other regulatory expenses 0.25

Listing Day Trading Information

Price DetailsNSE SME
Final Issue Price96.00
Open132.50
Low125.90
High135.85
Last Trade126.20

Check IPO Performance…

IPO Registrar

Maashitla Securities Pvt.Ltd.

Contact Details

Influx Healthtech Ltd. Address
109, Ghanshyam Enclave Premises Co-op
Soc Plot No. 856, Laljipada
Kandivali West,
Mumbai, Maharashtra, 400067
Open an Instant Account with Zerodha

IPO FAQs

Influx Healthtech IPO is a SME IPO of 61,00,800 equity shares of the face value of ₹10 aggregating up to ₹59 Crores. The issue is priced at ₹96 per share. The minimum order quantity is 1200.

The IPO opens on Wed, Jun 18, 2025, and closes on Fri, Jun 20, 2025.

Maashitla Securities Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Zerodha customers can apply online in Influx Healthtech IPO using UPI as a payment gateway. Zerodha customers can apply in Influx Healthtech IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Influx Healthtech IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Influx Healthtech IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. Submit IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Influx Healthtech IPO opens on Wed, Jun 18, 2025 and closes on Fri, Jun 20, 2025.

Influx Healthtech IPO lot size is 1200, and the minimum amount required for application is ₹1,15,200.

You can apply in Influx Healthtech IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Influx Healthtech IPO will be done on Monday, June 23, 2025, and the allotted shares will be credited to your demat account by Tue, Jun 24, 2025. Check the Influx Healthtech IPO allotment status.

The Influx Healthtech IPO listing date is on Wed, Jun 25, 2025.

Compare: